MYRIAD GENETICS INC — Director's Dealing 2013

Nov 8, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2013-11-06

Reporting Person: MELDRUM PETER D (Director, President & C.E.O.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-06	Common Stock	G	30000.0	$0.0	Disposed	56158	Direct
2013-11-07	Common Stock	G	502.0	$0.0	Disposed	55656	Direct
2013-11-08	Common Stock	M	20000.0	$5.89	Acquired	75656	Direct
2013-11-08	Common Stock	S	20000.0	$26.524	Disposed	55656	Direct
2013-11-08	Common Stock	M	11784.0	$6.0	Acquired	67440	Direct
2013-11-08	Common Stock	S	11784.0	$26.464	Disposed	55656	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-11-08	Non-Qualified Stock Option (right to buy)	$5.89	M	20000.0	Disposed	2014-09-08	Common Stock (20000)	Direct
2013-11-08	Non-Qualified Stock Option (right to buy)	$6.0	M	11784.0	Disposed	2014-02-19	Common Stock (11784)	Direct

Footnotes

F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.